On June 18, 2024, Stoke Therapeutics, Inc. and Huw Nash, Ph.D., the Company's Chief Operating Officer and Chief Business Officer, announced that they have mutually agreed that Dr. Nash would step down from his position as Chief Operating Officer, effective immediately. Dr. Nash will continue to serve and perform his duties as Chief Business Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.25 USD | +1.57% |
|
+8.61% | +170.91% |
Jul. 01 | Stoke Therapeutics, Inc.(NasdaqGS:STOK) added to Russell Microcap Growth Index | CI |
Jul. 01 | Stoke Therapeutics, Inc.(NasdaqGS:STOK) dropped from Russell Microcap Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+170.91% | 743M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Dr. Huw Nash Steps Down as Chief Operating Officer of Stoke Therapeutics, Inc